Phase 2 Randomized Clinical Study of Netarsudil Ophthalmic Solution in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

被引：0
|
作者：
Makoto Araie
Kazuhisa Sugiyama
Kenji Aso
Koji Kanemoto
Kalyani Kothapalli
Casey Kopczynski
Michelle Senchyna
David A. Hollander
机构：
[1] Kanto Central Hospital of the Mutual Aid Association of Public School Teachers,Department of Ophthalmology
[2] Kanazawa University Graduate School of Medical Science,undefined
[3] Aerie Pharmaceuticals Ireland Ltd. (Japan Branch),undefined
[4] Statistics and Data Corporation,undefined
[5] Aerie Pharmaceuticals,undefined
[6] Inc.,undefined
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Conjunctival hyperemia; Glaucoma; Intraocular pressure; Netarsudil; Rho-associated protein kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1757 / 1775
页数：18
相关论文
共 50 条
  • [21] Pharmacotherapy Compliance in Patients with Ocular Hypertension or Primary Open-Angle Glaucoma
    Traverso, Carlo E.
    Walt, John G.
    Stern, Lee S.
    Dolgitser, Margarita
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (01) : 77 - 82
  • [22] Functional parameters in patients with ocular hypertension and primary open-angle glaucoma
    Salomone, Mariella
    Verboschi, Francesca
    Fragiotta, Serena
    Valente, Stefano
    Domanico, Daniela
    Spadea, Leopoldo
    Vingolo, Enzo M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [23] MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
    Ingeborg Stalmans
    Kin Sheng Lim
    Francesco Oddone
    Marek Fichtl
    Jose I. Belda
    Anton Hommer
    Guna Laganovska
    Cédric Schweitzer
    Bogomil Voykov
    Tomasz Zarnowski
    Gábor Holló
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 179 - 190
  • [24] MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
    Stalmans, Ingeborg
    Lim, Kin Sheng
    Oddone, Francesco
    Fichtl, Marek
    Belda, Jose I.
    Hommer, Anton
    Laganovska, Guna
    Schweitzer, Cedric
    Voykov, Bogomil
    Zarnowski, Tomasz
    Hollo, Gabor
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (01) : 179 - 190
  • [25] Correction to: Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
    Sheridan M. Hoy
    Drugs, 2018, 78 : 857 - 857
  • [26] Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
    Dasso, Lily
    Al-Khaled, Tala
    Sonty, Sriram
    Aref, Ahmad A.
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1939 - 1944
  • [27] Brimonidine purite solution for open-angle glaucoma or ocular hypertension
    Batiste, Corey G.
    Myers, Jonathan
    Katz, L. Jay
    EXPERT REVIEW OF OPHTHALMOLOGY, 2008, 3 (05) : 513 - 515
  • [28] MICROCIRCULATION AND HEMODYNAMICS IN OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    ALEXEEV, BN
    SHMYREVA, VF
    MOSTOVOI, EN
    VESTNIK OFTALMOLOGII, 1986, (05) : 8 - 10
  • [29] Health care charges for patients with ocular hypertension or primary open-angle glaucoma
    Pasquale, Louis R.
    Dolgitser, Margarita
    Wentzloff, Jeffrey N.
    Stern, Lee S.
    Doyle, John J.
    Chiang, Tina H.
    Walt, John G.
    OPHTHALMOLOGY, 2008, 115 (04) : 633 - 638
  • [30] Netarsudil/latanoprost fixed-dose combination for the treatment of open-angle glaucoma or ocular hypertension
    Radell, J. E.
    Serle, J. B.
    DRUGS OF TODAY, 2019, 55 (09) : 563 - 574
12345